Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma
1 vistas
• 08/09/23
0
0
Empotrar
administrator
Suscriptores
Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios